Wire Stories
Teijin Receives Marketing Approval for Merz�s Xeomin� Botulinum Toxin Type A in Japan
FRANKFURT, Germany–(BUSINESS WIRE)–#Merz–Merz Pharmaceuticals GmbH, a leading neurotoxin company and subsidiary of Merz Pharma GmbH & Co. KGaA, and Teijin Pharma Limited,...